NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 161 filers reported holding NEVRO CORP in Q3 2019. The put-call ratio across all filers is 2.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $15,000 | -11.8% | 331 | +38.5% | 0.00% | – |
| Q1 2022 | $17,000 | -15.0% | 239 | -4.0% | 0.00% | – |
| Q4 2021 | $20,000 | +33.3% | 249 | +88.6% | 0.00% | – |
| Q3 2021 | $15,000 | -58.3% | 132 | -39.4% | 0.00% | – |
| Q2 2021 | $36,000 | +176.9% | 218 | +139.6% | 0.00% | – |
| Q1 2021 | $13,000 | -56.7% | 91 | -46.8% | 0.00% | – |
| Q4 2020 | $30,000 | +25.0% | 171 | -1.7% | 0.00% | – |
| Q3 2020 | $24,000 | +20.0% | 174 | +3.0% | 0.00% | – |
| Q2 2020 | $20,000 | +400.0% | 169 | +267.4% | 0.00% | – |
| Q3 2019 | $4,000 | -20.0% | 46 | -37.0% | 0.00% | – |
| Q2 2019 | $5,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q1 2019 | $5,000 | 0.0% | 73 | -37.6% | 0.00% | – |
| Q4 2018 | $5,000 | -28.6% | 117 | 0.0% | 0.00% | – |
| Q3 2018 | $7,000 | -22.2% | 117 | 0.0% | 0.00% | – |
| Q2 2018 | $9,000 | +800.0% | 117 | +1571.4% | 0.00% | – |
| Q1 2018 | $1,000 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,776,368 | $34,141,793 | 1.08% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $66,424,320 | 1.02% |
| Palo Alto Investors LP | 386,832 | $7,434,911 | 0.70% |
| Rock Springs Capital Management LP | 1,211,600 | $23,286,952 | 0.62% |
| ArrowMark Colorado Holdings LLC | 2,468,110 | $47,437,074 | 0.58% |
| TD Capital Management LLC | 84,648 | $1,626,935 | 0.20% |
| Venator Management LLC | 25,000 | $480,500 | 0.18% |
| DAFNA Capital Management LLC | 28,000 | $538,160 | 0.17% |
| FRED ALGER MANAGEMENT, LLC | 1,053,812 | $20,254,266 | 0.12% |
| Counterpoint Mutual Funds LLC | 6,844 | $131,542 | 0.11% |